More news about Clinerion

Ian Rentsch takes over from Ulf Claesson

19.03.2018 16:22

Related tags

ian Rentsch Clinerion

Digital health company Clinerion has already a global footprint. Clinerion’s Board of Directors appointed Ian Rentsch as new CEO of the company. He shall take the company to the next level.  

Clinerion is now well established as the leading supplier of patient data analytics services for clinical trial patient search and identification, and data generation for real-world evidence and market access. The company has access to currently more than 180 million patients’ data around the world.

“We have a truly global footprint and we are poised to expand further around the world. We can support international studies wherever they may have recruitment needs. Ian Rentsch is the right person to take the company to the next level of success,” says Ulf Claesson, current CEO and Board Director of Clinerion. Ian Rentsch’s effective start date as CEO of Clinerion will be April 1, 2018.

Rentsch brings more than 22 years of international experience in multinational pharmaceutical companies as well as in small/niche and global CROs. He joined the former Quintiles – now IQVIA – in 2012, as Head of Latin America Sales, and relocated to Europe to lead the Emerging Biopharma Segment in EMEA as Regional Head. Most recently, he took on the role of Global Demand and Business Operations Head of an E2E Strategic Alliance. Rentsch has a German-Argentinian background and is a lawyer (UBA) and Industriekaufmann (IHK) by training.

“Ulf Claesson will continue to add his tremendous know-how to the company strategy at the board level. He has built Clinerion into a vibrant, dynamic company with a world-class team capable of moving mountains! Clinerion is in position to radically speed up clinical research to the benefit of patients around the world. Ulf has done an invaluable job in building the technological and data fundaments of Clinerion and we are fortunate to continue to have him on the Board. I’m also very happy to have in Ian a new CEO who will build the bridge between our groundbreaking offering and customers in the increasingly digitalizing healthcare environment,“ says Pierre Jaccoud, Co-Founder and Chairman of Clinerion’s Board of Directors.

Clinerion enables early patient access to innovative treatments through solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion's PRS accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment. Clinerion’s key patient data services include data-assisted protocol optimization, site feasibility evaluation and patient identification. Clinerion’s solutions allow member hospitals to participate in leading-edge, industry-sponsored trials and save time in patient recruitment. They enable pharmaceutical companies to gain time and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which remain under the full control of participating hospitals. Clinerion's solutions comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

(Press release)

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines


A showcase for female CEOs

Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.



By continuing to use this website you agree with our TERMS AND CONDITIONS